Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$773.9M
-44.2% from 2023
Prescriptions
2.8M
$272.99 per claim
Patients
2.8M
72,027 prescribers
Total spending, 2024
$774.2M
$274.50 per patient
Medicare prescription drug plans paid $773.9M for Arexvy in 2024, for 2,835,007 prescriptions and refills to 2,819,376 patients (down 44.2% from 2023). The average cost per claim was $272.99.
California had the highest Medicare cost for Arexvy in 2024: $88.1M for 329,071 claims, followed by Illinois ($72.3M).
Armaghan Azad, emergency medicine in Moreno Valley, CA, had the highest Medicare cost for Arexvy in 2024: 182,500 claims costing $48.6M.
Arexvy is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Armaghan Azad Moreno Valley, CA | Emergency Medicine | 182,500 | 181,806 | $48.6M |
| Cedric E Davis II Parker, AZ | Family Practice | 134,247 | 133,735 | $34.2M |
| Shaun D Gill |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 65,845 | 4,394,584 | 4,388,873 | $1.39B |
| 2024 | 72,027 | 2,835,007 | 2,819,376 | $773.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hospitalist |
| 61,658 |
| 61,446 |
| $17.5M |
| Daniel R Bauer Charlotte, NC | Internal Medicine | 63,048 | 62,858 | $16.8M |
| Rushdi Alul Chicago, IL | Emergency Medicine | 59,350 | 59,175 | $16.6M |
| Eldridge G Burns Jr. Seward, NE | Family Practice | 63,932 | 63,724 | $16.5M |
| Richard D Clark Marietta, OH | Family Practice | 58,868 | 58,660 | $16.0M |
| John R Bogdasarian Fitchburg, MA | Otolaryngology | 56,818 | 56,583 | $15.9M |
| Ruth E Mays Highland Park, MI | Family Practice | 53,009 | 52,867 | $15.1M |
| Ikenna S Nzeogu Tazewell, VA | Internal Medicine | 50,614 | 50,429 | $13.8M |
| Lindsay M Weaver Indianapolis, IN | Emergency Medicine | 51,834 | 51,659 | $13.8M |
| Annette V Wagner Wilkes Barre, PA | Obstetrics & Gynecology | 42,775 | 42,549 | $12.1M |
| Jason A Torrente Hamilton, NJ | Family Practice | 44,697 | 44,543 | $11.6M |
| Anthony J Oliva Jr. San Antonio, TX | Internal Medicine | 45,882 | 45,768 | $11.3M |
| Jai G Wadhwani Williamsville, NY | Cardiology | 41,878 | 41,770 | $11.3M |
| Martin A Duclos Conway, SC | Internal Medicine | 35,769 | 35,649 | $9.6M |
| Weslin Thomas Des Plaines, IL | Family Practice | 35,277 | 35,254 | $9.3M |
| Vince Faridani Pembroke Pines, FL | Internal Medicine | 30,237 | 30,134 | $8.3M |
| Winnie L Mann Redmond, WA | Specialist | 27,471 | 27,444 | $8.1M |
| Michael Stanford Trussville, AL | Family Practice | 29,650 | 29,500 | $7.9M |
| Krishdeep Khosla Oakbrook Terrace, IL | Internal Medicine | 23,995 | 23,880 | $7.2M |
| Alejandra Moscoso-Agosto McKinney, TX | Family Practice | 28,353 | 28,321 | $7.0M |
| Karen M Donaldson Baltimore, MD | Family Practice | 23,410 | 23,297 | $6.4M |
| Daisy-Scarlett Maccallum Walnut Creek, CA | Family Practice | 21,638 | 21,558 | $6.3M |
| Marc R Watkins Nashville, TN | Preventive Medicine | 17,508 | 17,504 | $5.4M |
| Spending |
|---|
| Glaxosmithkline GSK | 2,835,981 | $774.2M |